Cohesin is a protein complex encircles the DNA and regulates the separation of sister chromatids during cell division. Following a catalytic mechanism that is insufficiently understood, Esco1 and Esco2 acetyltransferases acetylate Smc3 subunit of cohesin, thereby inducing a stabilization of cohesin on DNA. As a prerequisite for structureguided investigation of enzymatic activity, we determine here the crystal structure of the mouse Esco2/CoA complex at 1.8 Å resolution. We reconstitute the entire cohesin as a tetrameric assembly and use it as a physiologically-relevant substrate for enzymatic assays in vitro. Furthermore, we employ cell-based complementation studies in mouse embryonic fibroblast deficient for Esco1 and Esco2, as a means to identify catalytically-important residues in vivo. These analyses demonstrate that D567/S566 and E491/S527, located on opposite sides of the MmEsco2 active site cleft, are critical for catalysis. Our experiments supports a catalytic mechanism of acetylation where residues D567 and E491 are general bases that deprotonate the εamino group of lysine substrate, via two nearby serine residues -S566 and S527-that possess a proton relay function.
Introduction
Cohesin is a ring-like protein complex that is composed of the four subunits Smc1, Smc3, Scc1/Rad21, and Scc3/SA. Smc1 and Smc3 belong to the family of SMC (structural maintenance of chromosomes) proteins, which contain ATPase head domains. Cohesin topologically traps chromatin inside its ring structure, functioning as a molecular connector that ensures equal segregation of sister chromatids during mitosis [1] [2] [3] [4] . Additionally, cohesin facilitates postreplicative homologous recombination repair of double-strand DNA breaks, and regulates gene expression via the formation of chromatin loops [5] [6] [7] [8] [9] . Cohesin is loaded onto chromatin by the Scc2-Scc4 loader complex and released by Wapl and Pds5 [10] [11] [12] [13] [14] [15] . Both cohesin loading and unloading depend on the ATPase activity of the Smc head domain 10, [16] [17] [18] [19] .
Once loaded, DNA interacts with a basic patch residing on the Smc3 head domain and thereby stimulates its ATPase activity. A notable structural feature of this basic patch is the presence of two neighboring conserved lysines 19, 20 . Acetylation of these residues by yeast acetyltransferase Eco1 or its mammalian orthologues Esco1 and Esco2 (establishment of cohesion) decreases the positive charge of the patch, which weakens DNA binding and lessens ATPase activity 19 . This in turn counteracts the activity of the release factors Wapl-Pds5. As a result, Esco activity stabilizes cohesin on DNA 21 . In vertebrates, cohesion establishment additionally involves Sororin, which competes with Wapl for binding to Pds5 and in this way counteracts the releasing activity of Wapl-Pds5 22, 23 .
Esco1 and Esco2 belong to the GNAT (GCN5-related N-acetyltransferase) family. These two isozymes consist of divergent N-termini, followed by a C2H2 zinc finger and a conserved C-terminal acetyltransferase domain 24 . Esco1 and Esco2 differ in several respects. Esco1 is evenly expressed throughout the cell cycle, while Esco2 is highly abundant during the S-phase 25, 26 . Esco1 but not Esco2 directly interacts with cohesin via Pds5 27 . Esco2 interacts with the replication proteins, PCNA (proliferating cell nuclear antigen) 28, 29 and MCM (minichromosome maintenance protein complex) 30, 31 . Esco1 mutation is associated with endometrial cancer 32 and mutations in Esco2 cause RBS (Roberts syndrome), a congenital disease [33] [34] [35] . In RBS metaphase chromosomes show a loss of cohesion in the PCH (pericentric heterochromatin) while cohesion is maintained in the arms 36 . A significant fraction of Esco1-deficient mice is viable (this study), while Esco2-deficient mice always die early in development 26 .
An acetyltransferase typically employs a general base to deprotonate the ε-amino group of a substrate lysine which initiates acetyl transfer from AcCoA.
Intriguingly, crystal structure of human acetyltransferase HsESCO1, reported by Kouznetsova et al., led the authors to propose that the general base is provided by the substrate rather than the enzyme. Thus, D107 of SMC3 might deprotonate K105 and K106 of SMC3 37 . In contrast, Rivera-Colon et al. proposed that D810 of HsESCO1 plays the role of a general base. Indeed, mutating this aspartate to asparagine abrogates acetylation of an Smc3 peptide mimicking SMC substrate 38 . A subsequent study by Chao et al. has observed that in the Xenopus xEco2/Smc3 peptide structure, the Smc3 D107 does not point towards the ϵ-amino group of the substrate lysines but interacts with two conserved R621 and W623 residues of xEco2. This suggests that D107 of Smc3 plays a role tethering the enzyme to the substrate , rather than acting as a general base 39 . In agreement with Rivera-Colon et al., Chao et al. propose that D677 (the equivalent of D810 of HsESCO1) could serve as a general base. However, both studies noted that this particular aspartic acid is not strictly conserved among Esco homologs, suggesting that other residues at the active site may also contribute to catalysis.
To shed light into the catalytic mechanism of Esco1 and Esco2, we determine the crystal structure of murine Esco2 in complex with CoA at atomic resolution, establish a robust framework for assessing enzymatic activity in vitro and in vivo, and perform mutagenic analysis of the active center. An alternative catalytic model is proposed.
Results

Structure of MmEsco2 368-592 in complex with Coenzyme A.
We crystallized MmEsco2 368-592 protein consisting of the C2H2 zinc finger and the acetyltransferase domain. Crystals diffracted to 1.8 Å resolution. By making use of the natively bound zinc ion, the crystal structure was determined by SAD (singlewavelength anomalous dispersion) from a dataset collected at the zinc peak wavelength ( Supplementary Table S1 ). The refined MmEsco2 368-592 structure revealed continuous electron density, except for two short, structurally disordered and hence unresolved regions (residues 368-383 and 501-514, Fig. 1A ). The zinc finger (residues 385-416), is located N-terminally of the catalytic domain, and consists of two β-strands and one α-helix that encircle the zinc ion ( Fig. 1B) . Residues 423-592 of MmEsco2 368-592 reveal an overall fold similar to that of other GNAT family acetyltransferases 40 . This fold consists of a conserved catalytic domain (β5, β6, β7, α3, and α4), which is flanked by structurally variable regions (Fig. 1B) . The CoA cofactor is natively present in a complex with MmEsco2 in a groove formed by β7 and β8 strands and α3 and α4 helices ( Fig. 1B ). This is reminiscent of the position of the CoA or AcCoA in other GNAT family members 40 .
The active site architecture of MmEsco2 368-592 and identification of candidate catalytic residues.
We searched for residues in the active site cleft of MmEsco2 368-592 , which could act as a general base for catalyzing the nucleophilic attack of the lysine ε-amino group on the AcCoA thioester bond. Structural superposition with xEco2 in complex with a Smc3 peptide conjugated with CoA at K105 39 , enabled identification of candidate catalytic residues in MmEsco2, with reference to the ε-amino group of K105. The most obvious candidate residue is D567 that may act in conjunction with S566; the latter potentially acting as a proton relay. Noteworthy, the equivalent D810 was previously suggested as general base in HsESCO1 38 (for an overview of residues equivalence, see Fig. 1C ).
S566 and D567 are located at the CoA binding pocket, S566 in the C-terminus of the β8 strand and D567 in a flexible loop connecting β8 strand and α4 helix ( Fig. 2A) . The γ-oxygen of S566 and δ-oxygen of D567 are ~ 5 and ~ 4.4 Å away from the ε-amino group of K105 ( Fig. 2A ). The distance of the δ-oxygen of D567 and the γ-oxygen of S566 is 5.7 Å, consistent with a proton relay function. We also considered S527 as a possible relay, with its γ-oxygen being ~ 8.7 Å away from ε-amino group of K105 ( Fig.   2A ). E491 could serve as general base. Its ε-oxygen of is ~ 9.8 Å away from ε-amino group of K105. Notably, a water molecule located in between these four residues and CoA, similar to the one observed in the xEco2/K106-CoA structure 39 , might be involved in proton transfer ( Fig. 2B ). E491, S527 and S566 residues are invariant among Esco homologs. D567 residue is also highly conserved except for yeast Eco1 where this residue is a glutamine (Fig. 1A ).
Establishing of an acetylation assay that mimic the physiological conditions
To investigate whether the selected candidate residues contribute to catalysis, we mutated S566 and/or D567 and measured catalytic activities with trimeric or tetrameric cohesin ring substrates. Expression of full-length MmEsco1 and MmEsco2 wild type proteins gave very low yields, but recombinant full-length HsESCO1 was readily expressed in Sf9 cells ( Supplementary Fig. S1A ). Of note, the structure of the active site of MmEsco2 and HsESCO1 are very similar ( Supplementary Fig. S2A ). Thus, we applied HsESCO1 for the following reconstitution-based assays.
A major drawback of the enzymatic assays reported before for Esco proteins is that either autoacetylation or acetylation of peptide mimetics were used, rather than physiological substrates. Recombinant cohesin assembled as a trimer was also employed, although it does not thoroughly represent physiological substrate 41 . To enhance the relevance and accuracy of our observations, we therefore decided to reconstitute entire cohesin rings recombinant and use them for enzymatic assays.
We first generated human trimeric ( Supplementary Fig. S1B ) and tetrameric recombinant cohesin as previously described 41 . Trimeric and tetrameric substrates were acetylated by HsESCO1, at K105 and K106 of SMC3 in the presence of ATP, circular, linear or relaxed DNA (Figs. 3A and 3B). To detect SMC3 acetylation, we used a monoclonal antibody that specifically recognizes Smc3 singly acetylated on K106 or doubly acetylated on K105 and K106 23 . Acetylation was not detected in reconstituted cohesin substrate when ATP hydrolysis was inhibited 41 ( Supplementary Fig. S1C ) or DNA was absent (Figs. 3A and 3B). Importantly, tetrameric substrate was much more efficiently acetylated than trimeric cohesin (Figs. 3C and 3D). We conclude that in presence of ATP and DNA, HsESCO1 efficiently acetylates cohesin rings. Given that cohesin rings are efficiently acetylated only in the tetrameric form, and that acetylation is dependent of ATP and DNA, we conclude that the assay that we established recapitulates to a good extent the expected occurrence of HsEsco1 acetylation under physiological conditions.
Mutations in putative catalytic residues affect acetyltransferase activity of Esco1
in reconstituted in vitro assay.
Having the mimicking physiological reconstituted system at hand, we next quantified the rate of SMC3 acetylation for site-directed mutants of residues S809 and D810.
Recombinant mutant proteins HsESCO1 S809A , HsESCO1 S809C , HsESCO1 D810A , and HsESCO1 D810N were produced at similar levels as wild-type controls, except for HsESCO1 S809A which gave a lower yield. Recombinant proteins were incubated with cohesin tri-and tetrameric complexes. Wild-type HsESCO1 efficiently acetylated both substrates (Figs. 3E, 3F, 3G and 3H). Remarkably, none of the mutant proteins acetylate cohesin trimers or tetramers (Figs. 3E, 3F, 3G, and 3H). Rivera-Colon et al. 38 reported that wild-type protein and the four mutants used here show similar thermal stability, arguing against the possibility that mutant HsESCO1 proteins were unfolded and hence became catalytically inactive. Together, these results indicate that D810 and the neighboring S809 are required for catalytic activity of the HsESCO1 enzyme, when using reconstituted recombinant cohesin substrates. We infer from the HsESCO1 experiments that S566 and D567 of MmEsco2 are catalytic residues.
Mutations in putative catalytic residues affect acetyltransferase activity of Esco1 and Esco2 in cells.
The existing interactions between several accessory proteins and the tetrameric cohesin ring rises the possibility that the former affect the geometry of the active site pocket and the way substrates bind. Therefore, we asked whether the serine and aspartic acid mutants, completely inactive in the above reconstitution assays, are also catalytically inactive when assayed in MEFs. These cell-based complementation assays involve transfection of full-length wild-type or mutant MmEsco1/2 into MEFs lacking either MmEsco1 or MmEsco2.
To obtain Esco1-deficient MEFs (MEFs Esco1-/-), an Esco1 conditional knockout mouse was generated using the Cre/LoxP system allowing deletion of exons 2 and 3 (Supplementary Figs. S3A-S3D). MEFs Esco1-/were arrested in G1 ( Fig. 4A ), showed a strong reduction in Smc3 acetylation compared to controls ( Fig. 4B ). Residual Smc3 acetylation is likely due to MmEsco2 that is present at low-amounts during the G1-phase 25, 26 . Transfection of MEFs Esco1-/with MmEsco1-myc restored strong Smc3 acetylation ( Fig. 4B ). Next, we transiently transfected MEFs Esco1-/with single residue mutants that were catalytically inactive in the in vitro reconstitution experiments (Figs.
3E-3H
). It should be noted that all MmEsco1 mutants tested were chromatin bound ( Supplementary Fig. S4C ). Transfection of MEFs Esco1-/with MmEsco1 S812A , MmEsco1 S812C , and MmEsco1 D813A showed significant acetyltransferase activity, reaching up to 30 to 50% of wild-type level in contrast to the reconstitution-based assays (Figs. 4C and 4D). Note that mutant and wild-type cells were equally arrested in G1 ( Supplementary Fig. S4A ). Consistently, we find that S812A;S773A double mutants are nearly inactive (Figs. 4C and 4D).
Rivera-Colon
So far, we identified several MmEsco1 residues that mediate Smc3 acetylation in cells. We next examined whether the corresponding residues are also involved in catalysis in MmEsco2. Wild-type, Esco2 -/-26 , and Esco2 -/-;Esco2-myc MEFs were arrested in S-phase ( Fig. 5A) at which time endogenous MmEsco2 is known to be maximally expressed 25, 26 . Consistent with previous published data 26 , MEFs Esco2-/showed a 60% reduction in Smc3 acetylation compared to controls (Figs. 5B and 5D). Residual Smc3 acetylation is most likely due to MmEsco1, which is expressed throughout the cell cycle 25, 26 (Figs. 5C and 5D; for synchronization of mutant cells see Supplementary Fig. S4B ).
While these results are in close agreement with the effect of the same mutants on MmEsco1 activity, the effect of single mutations (S566A, D567A, S527A and E491Q) on Smc3 acetylation was slightly less pronounced than that observed for MmEsco1. For instance, MmEsco2 S566A and MmEsco2 S527A showed up to 60-80% residual acetyltransferase activity relative to wild-type (Figs. 5C and 5D). In the case of Esco1, the residual activity was in the 30-50% range. In addition, MmEsco2 D567A and MmEsco2 E492Q single mutants acetylated Smc3 to the same extent as its wild-type control (Figs. 5C and 5D). These differences between Esco1 and Esco2 might be caused by the different chromatin context in which the two enzymes act.
In summary, our data indicate that both MmEsco1 and MmEsco2 engage alternative catalytic residues, supporting a shared mechanism of acetylation, in spite of the distinct biological contexts where the two enzymes function.
Effect of catalytic mutants of MmEsco2 on sister chromatid cohesion.
RBS patients are characterized by loss of function mutations in HsESCO2 causing sister chromatid cohesion defects 34, 35 . Such defects are also seen in Esco2-deficient MEFs ( Fig. 5E; 26 ). We examined which of the MmEsco2 mutants lead to a cohesion defect phenotype. MEFs Esco2-/were stably transfected with wild-type or different mutant versions of MmEsco2, and were synchronized in prometaphase, isolated by mitotic shake-off, and used for chromosome spread preparations. Consistent with the Smc3 acetylation experiments (Figs. 5C and 5D), chromosome morphology analysis revealed that the single mutants MmEsco2 S566A , MmEsco2 D567A , MmEsco2 S527A , and MmEsco2 E491Q that still enable acetyltransferase activity (Figs. 5C and 5D) restore wild-type appearance of cohesion, to a good extent ( Fig. 5F ). However, catalytically inactive single or double mutants MmEsco2 D567N , MmEsco2 S566A;D567A and MmEsco2 S527A;S566A , exhibited strong sister chromatid cohesion defects ( Fig. 5F ). As would be expected, the sister chromatid cohesion assay points to the same catalytic residues as the acetylation assays.
Discussion
The initial step of a lysine acetyltransferase reaction is deprotonation of the ε-amino group of substrate lysine, mediated by a general base, most commonly an aspartate or a glutamate. Subsequently, the deprotonated ε-amino group carries out a nucleophilic attack on the carbonyl carbon of enzyme-bound AcCoA. This eventually results in the transfer of the acetyl moiety from AcCoA to the substrate lysine.
The active site cleft of Esco acetyltransferases has two walls. One consists of α-helices 3 and 4 whose side chains position AcCoA and a loop that connects a short β-strand (β8) to α-helix 4. The opposite wall consists of β-strands 5, 6 and 7 (Figs. 1A and 1B). Candidate catalytic residues protrude from the walls ( Fig. 2A ). Previous attempts to identify catalytic residues by mutational analyses of Esco1 and Esco2 homologs did not arrive at the same results. In the case of HsESCO1 an aspartate residue belonging to the substrate has been proposed to act as a general base 37 .
However, in a more recent study 38 , this role was attributed to an aspartate (D810) from the active site of HsESCO1. Mutation of this highly conserved aspartate to an asparagine inactivated the enzyme, according to an enzymatic assay that made use of Smc3 peptide as a substrate. Crystal structure of xEco2, the Xenopus homolog of Esco1 and Esco2, complexed with an isolated peptide of the Smc3 substrate supports the catalytic role of this aspartate as a general base 39 .
Our own structure-function studies of MmEsco2 also identified this particular aspartate (D567 in MmEsco2, Fig. 6 ), located on the loop between β8 and α4, as a general base. A D567N mutation was enzymatically inactive in reactions using recombinant trimeric and tetrameric cohesins as substrates. Furthermore, this particular mutant failed to acetylate Smc3 in cells and establish sister chromatid cohesion.
Surprisingly, although mutation of D567 to an alanine abolished acetylation in vitro, the enzyme showed appreciable activity in vivo, as observed in two different cellbased assays. This indicates that the role of D567 as a general base is taken over by another residue. A possible candidate is E491, located on the β-strand 6 at the opposite of the CoA binding pocket ( Fig. 2A) . Mutation of the equivalent residue from HsESCO1 to a glutamine was previously shown to abolish acetylation of an SMC3 peptide 38 . Notably, this mutation reduces activity by 50% in cell-based assays, while the double mutant E491Q; D567A is completely inactive in cell-based assays. These observations support the view that both of these residues from the active site cleft act as general bases.
Serine residues, S527 and S566, are located in close proximity to E491 and D567, respectively ( Fig. 2A ). Mutation of S566 to either a cysteine or an alanine abolishes acetylation in vitro (Figs. 3E-3H ). However, both mutants were partially active in cell-based assays (Figs. 4C and 4D ). Crystal structure of MmEsco2 carrying the S566C mutation is virtually identical with the wild-type protein (data not shown), suggesting that substitution of this residue impairs catalysis rather than the structure.
Mutation of the second serine residue, such as S527A is known to abolish acetylation in vitro 38 . This is consistent with our observation that S527A reduces substantially acetyltransferase activity in cell-based assays (Figs. 4C and 4D ). Taken together, these experiments argue for roles of S527 and S566 in catalysis, possibly acting as a proton relay for E491 and D567 (Fig. 6 ). A proton relay function of serine has been proposed for the Dat acetyltransferase in which a glutamate residue deprotonates the substrate amino group through a serine residue 42 . Whether a nearby water molecule (Fig. 2B) is also involved in proton transfer is as yet unclear. In support of this idea is the finding that a water molecule is found at the same position in xEco2 39 .
Our work highlights the crucial importance of designing and employing suitable enzymatic assays, when complex substrates such as cohesin are involved. Firstly, we observed in vitro that the presence of SA1 in the composition of tetrameric cohesin (therefore a closer mimic of the physiological context) enables a notably more efficient acetylation than the trimeric version ( Figs. 3C and 3D ). Furthermore, mutations that abolish enzymatic activity versus this tetrameric cohesin substrate (e.g. S566A, S566C and D567A) still enable acetylation of cohesin in vivo, where even more factors are associated to cohesin. Although the residual activity is relatively weak, in one case can rich up to 50% of the wild-type activity ( Figs. 4C and 4D ). This is indicative for redundancy mechanisms that are at work in vivo, owing to additional cohesin regulators that are absent in vitro, such as Pds5A, Pds5B, MCM and chromatin 22, 27, 31 .
Furthermore, we noticed the identical mutations in either MmEsco1 or MmEsco2 evoke Smc3 acetylation deficiencies to a similar qualitative extent ( Figs 4D and 5D ).
Nonetheless, there are some quantitative differences. This difference between Esco1 and Esco2 might reflect the fact that they act in vivo in a very different molecular context and do not have identical binding partners.
Taken together, we propose that two general bases present in Esco enzymes abstract the substrate proton via serine residues ( Fig. 6 ). Presence of the catalytic residues D567 and S566 in the CoA binding wall of the active site cleft and E491 and S527 protruding from the wall made of β-strands 5, 6 and 7 suggest that the active sites of Esco1 and Esco2 could be mirror symmetrical. Esco1 and Esco2 sequentially acetylate two distinct, neighboring lysines located in the basic patch of Smc3 39 . An interesting possibility is that the "duplication" of the catalytic residues has evolved as a mechanism required for acetylation of both substrate lysine residues, without the need of dissociation and re-association of the enzyme-substrate complex.
Material and Methods
MmEsco2 368-592 cloning, expression and purification. Truncated MmEsco2 368-592 with a C-terminal His-tag was cloned into the pFL vector 43 . The expression construct was transformed into DH10MultiBacY cells and recombinant bacmid was purified with a QIAprep Spin Miniprep Kit (Qiagen). V0 and V1 virus generation was performed using SF9 cells as previously described 44 Diffraction data were collected at beamline PXII of SLS (Paul Scherrer Institute, Villigen, Switzerland), processed and scaled using XDS 45 . By making use of the natively bound zinc ion, the crystal structure was determined by single-wavelength anomalous dispersion (SAD) from a 2.3 Å dataset collected at the zinc peak wavelength (Native I in the Supplementary Table S1 ). The initial model was then refined against a dataset of higher resolution 1.77 Å (Native II in the Supplementary   Table S1 ). The final model was built manually using COOT32 46 and structure refinement was performed with Phenix33 47 . Cells were harvested after 24 h and synchronization was assessed by flow cytometry.
Human ESCO1 cloning, expression and purification
Wild-type and mutants MmEsco2-myc/his and H2B-mCherry were cloned into the pVITRO2-hygro-mcs vector (InvivoGen) in two steps. First, full-length MmEsco2 was cloned into the pcDNA3.1/myc-His vector (Thermo Fisher Scientific).
Subsequently, MmEsco2-myc/his and H2B-mCherry were amplified from the vectors pcDNA3.1/myc-His and pcDNA3-H2B-mCherry (Addgene, 20972), respectively, and cloned into the pVITRO2-hygro-mcs vector. Immortalized MEFs Esco2fl/fl were grown to confluence in standard medium and transduced with Ad-Cre-GFP adenoviruses (SignaGen) in low serum medium (DMEM, supplemented with 3% FBS). After two days, the medium was changed to fresh low-serum medium and cells were cultured for another 48 h. Immortalized MEFs Esco2-/were stably transfected with wild-type and mutant versions of Esco2. Clones were then screened using a plate reader by measuring mCherry fluorescence levels. Subsequently, clones that stably expressed the mutant proteins close to the endogenous MmEsco2 level were selected using Western blotting. For synchronization, cells were treated twice with 2 mM thymidine for 14 h with an intermittent release of 9 h. Cells were harvested 2 h after second thymidine release and further processed for subsequent analyses.
For whole-cell extracts, cells were collected, washed in 1x cold PBS, resuspended in 2x SDS loading buffer and sonicated. Chromatin fractionation was performed according to the protocol described 50 .
Prometaphase chromosome spreads and immunofluorescence analysis. MEFs
were grown in standard culture medium. Cells at 60% confluency were arrested using nocodazole (400 ng ml -1 ) for 4h. Mitotic cells were harvested by shaking off and incubated in 1 ml of 75 mM KCl for 20 min at 37 °C. Prometaphase chromosomes were fixed in methanol:acetic acid (3:1), dropped onto humidified positively charged microscope slides and visualized using DAPI staining.
Antibodies. Rabbit antibody against MmEsco1 was generated using a haemocyaninconjugated peptide comprising amino acids 521 to 606 of mouse Esco1 (1:1000). The following previously described custom-made antibodies were used: anti-Esco2 26
(1:1000), mouse anti-acetyl-Smc3 (a gift from K. Shirahige) 23 (1:1000). The following commercial antibodies were used: rabbit anti-Smc3 (Cell Signaling D47B5, 1:3000), HRP-conjugated mouse anti-TBP (Abcam 197874, 1:5000), HRP-conjugated mouse anti-His tag (Novus 31055H, 1:1000).
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